These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 37533738

  • 1. Twenty-four-color full spectrum flow cytometry panel for minimal residual disease detection in acute myeloid leukemia.
    Chen M, Fu M, Gong M, Gao Y, Wang A, Zhao W, Wu X, Wang H.
    Open Med (Wars); 2023; 18(1):20230745. PubMed ID: 37533738
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 3. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X, Wu Y, Li C, Shen K, Li R.
    Clin Lab; 2023 Jun 01; 69(6):. PubMed ID: 37307129
    [Abstract] [Full Text] [Related]

  • 4. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 01; 15(4):687-91. PubMed ID: 17708783
    [Abstract] [Full Text] [Related]

  • 5. Universal monitoring of minimal residual disease in acute myeloid leukemia.
    Coustan-Smith E, Song G, Shurtleff S, Yeoh AE, Chng WJ, Chen SP, Rubnitz JE, Pui CH, Downing JR, Campana D.
    JCI Insight; 2018 May 03; 3(9):. PubMed ID: 29720577
    [Abstract] [Full Text] [Related]

  • 6. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 May 03; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 7. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
    Cao H, Wang YZ, Wu HH, Chang Y, Hao L, Chen SS, Huang XJ, Lu DP, Liu YR.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan 03; 29(1):23-8. PubMed ID: 18512311
    [Abstract] [Full Text] [Related]

  • 8. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia].
    Guo R, Shen AL, Wang Y, Liu L, Zhang JF, Wang R, Li JY, Wu YJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct 03; 23(5):1231-4. PubMed ID: 26524014
    [Abstract] [Full Text] [Related]

  • 9. [Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia].
    Wang YZ, Chang Y, Zhu HH, Qin YZ, Li JL, Fu JY, Li LD, Chen SS, Huang XJ, Lu DP, Liu YR.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun 03; 14(3):427-32. PubMed ID: 16800913
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of aberrant phenotypes in acute myeloblastic leukemia.
    Macedo A, Orfão A, Vidriales MB, López-Berges MC, Valverde B, González M, Caballero MD, Ramos F, Martínez M, Fernández-Calvo J.
    Ann Hematol; 1995 Apr 03; 70(4):189-94. PubMed ID: 7748963
    [Abstract] [Full Text] [Related]

  • 12. Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry.
    Li W, Morgan R, Nieder R, Truong S, Habeebu SSM, Ahmed AA.
    Cytometry B Clin Cytom; 2021 Sep 03; 100(5):590-601. PubMed ID: 33197125
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H.
    Arch Med Res; 2014 May 03; 45(4):343-50. PubMed ID: 24751333
    [Abstract] [Full Text] [Related]

  • 15. Phenotypic analysis of CD34 subpopulations in normal human bone marrow and its application for the detection of minimal residual disease.
    Macedo A, Orfao A, Ciudad J, Gonzalez M, Vidriales B, Lopez-Berges MC, Martínez A, Landolfi C, Cañizo C, San Miguel JF.
    Leukemia; 1995 Nov 03; 9(11):1896-901. PubMed ID: 7475281
    [Abstract] [Full Text] [Related]

  • 16. Immunophenotypic pattern of myeloid populations by flow cytometry analysis.
    Gorczyca W, Sun ZY, Cronin W, Li X, Mau S, Tugulea S.
    Methods Cell Biol; 2011 Nov 03; 103():221-66. PubMed ID: 21722806
    [Abstract] [Full Text] [Related]

  • 17. NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.
    Liu YR, Zhu HH, Ruan GR, Qin YZ, Shi HX, Lai YY, Chang Y, Wang YZ, Lu D, Hao L, Li JL, Li LD, Jiang B, Huang XJ.
    Leuk Res; 2013 Jul 03; 37(7):737-41. PubMed ID: 23601747
    [Abstract] [Full Text] [Related]

  • 18. Development of a 27-color panel for the detection of measurable residual disease in patients diagnosed with acute myeloid leukemia.
    Soh KT, Conway A, Liu X, Wallace PK.
    Cytometry A; 2022 Nov 03; 101(11):970-983. PubMed ID: 35716345
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.